TLIS News

The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider Cloopen Group (RAAS), which bagged the biggest pop of 2021 to date. Bumble (BMBL) priced further...read more

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised $221 million by offering 13.8 million shares at $16, the high end of the $14 to $16 range. Talis originally filed to sell 10 million shares, before increasing the offering to 11.5 million shares on Thursday, and further upsizing the deal at pricing. Talis's IPO follows that...read more

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised the proposed deal size for its upcoming IPO on Thursday. The Menlo Park, CA-based company now plans to raise $173 million by offering 11.5 million shares at a price range of $14 to $16. The company had previously filed to offer 10 million shares at the same range. At the...read more

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, announced terms for its IPO on Monday. The Menlo Park, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Talis Biomedical would command a fully diluted market value of $829 million. ...read more